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Abstract Inflammation originating from the adipose tis-
sue is considered to be one of the main driving forces
for the development of insulin resistance and type 2
diabetes in obese individuals. Although a plethora of
different immune cells shapes adipose tissue inflamma-
tion, this review is specifically focused on the contribu-
tion of macrophages that reside in adipose tissue in lean
and obese conditions. Both conventional and tissue-
specific functions of adipose tissue macrophages
(ATMs) in lean and obese adipose tissue are discussed
and linked with metabolic and inflammatory changes
that occur during the development of obesi ty.
Furthermore, we will address various circulating and
adipose tissue-derived triggers that may be involved in
shaping the ATM phenotype and underlie ATM function
in lean and obese conditions. Finally, we will highlight
how these changes affect adipose tissue inflammation
and may be targeted for therapeutic interventions to im-
prove insulin sensitivity in obese individuals.
Highlights
• Macrophages play a significant role in regulating adipose
tissue functioning during health and disease
• In addition to conventional functions such as clearing
cellular debris and participating in tissue immune surveil-
lance, lipid buffering is an important function of ATMs
• Obesity-induced inflammation, characterised by an ele-
vated number of proinflammatory macrophages in adi-
pose tissue, has been suggested to contribute to systemic
insulin resistance
• Their origin, as well as a combination of peripheral
changes and adipose tissue-derived stressors, probably
contribute to ATM dysfunction and inflammatory traits
during obesity
• Identification of transcriptional differences between
ATMs from lean vs obese adipose tissue at several key
points during the development of obesity and insulin re-
sistance may reveal upstream triggers, regulatory factors
and intracellular pathways that shape ATM function
• Targeting metabolic capacity rather than the inflamma-
tory phenotype of ATMs may hold potential to restore
ATM function and adipose tissue homeostasis in obese
individuals
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Introduction
Historically, adipose tissue is known to perform a number of
functions including storage of excess energy, cold insulation
and protection of vital organs. Intense research efforts over the
last decades have greatly furthered our understanding of adi-
pose tissue biology and led to the identification of various
additional functions. The adipose tissue—composed of adipo-
cytes and non-adipocyte cells, including endothelial cells, pre-
adipocytes and various types of immune cells [1]—is known
to produce and secrete a wide variety of so-called adipokines.
The release of adipokines enables communication with other
cells and tissues throughout the body involved in the regula-
tion of energy metabolism, satiety and various other
processes.
The central role of adipose tissue in homeostasis becomes
apparent during the development of obesity, which is a major
risk factor for the development of insulin resistance [2].
During the development of obesity, storage of excess amounts
of triacylglycerol in adipose tissue is associated with altered
release of adipokines and cytokines that control local and sys-
temic inflammatory processes and interfere with insulin sig-
nalling [3]. At the cellular level, it has been well established
that obesity promotes robust changes in adipose tissue mor-
phology [4]. In particular, hypertrophy of adipocytes and sig-
nificant alterations in the number and composition of immune
cells promote a state of chronic low-grade inflammation dur-
ing obesity that is strongly associated with the development of
insulin resistance and type 2 diabetes [1].
Macrophages are immune cells that have gained much at-
tention as important contributors to adipose tissue functioning.
Whereas macrophages in lean mice and humans make up
around 5% of the cells in adipose tissue, during obesity they
constitute up to 50% of all adipose tissue cells [5]. As well as
increasing in number, adipose tissue macrophages (ATMs)
change their localisation and inflammatory features during
obesity. Contrary to the lean state, in which ATMs are distrib-
uted throughout the adipose tissue exposing limited
inflammatory properties, ATMs in obese adipose tissue are
located around dead adipocytes and form so-called crown-like
structures (CLSs) while displaying profound proinflammatory
features [6–8]. Macrophage presence in CLSs within obese
adipose tissue has been directly linked with insulin resistance
[9, 10]. Notably, however, the importance of macrophage-
mediated inflammation in determining insulin resistance is
related to long-term exposure to a high-fat diet (HFD) whereas
the initial stage of insulin resistance is independent of macro-
phage action [11].
In contrast to mice, inflammatory changes in human adi-
pose tissue during obesity are somewhat less pronounced,
although the presence of CLSs is positively correlated with a
worsening in insulin resistance levels [12]. Furthermore, inter-
individual differences in the degree of adipose tissue inflam-
mation are likely to exist in humans and the importance of
macrophage-mediated adipose tissue inflammation on the de-
velopment of insulin resistance will vary between obese
individuals.
In addition to macrophages, numerous other types of im-
mune cell populate the adipose tissue and affect its function [5,
13]. Indeed, dendritic cells [14], mast cells [15], neutrophils
[16], B cells [17, 18] and T cells [19–21] have been found to
reside in adipose tissue during obesity and contribute to the
development of adipose tissue inflammation and insulin resis-
tance. In particular, neutrophils and CD8+ T cells have recent-
ly gained considerable attention because of the observed early
influx into adipose tissue upon HFD-feeding and their poten-
tial contribution either to attracting macrophages or affecting
their phenotype [16, 19, 22]. On the other hand, forkhead box
(FOX)P+ regulatory CD4+ T cells have been found to reduce
in number prior to the accumulation of macrophages in obese
adipose tissue [23]. In line with their well established role in
dampening proinflammatory signalling, reduced presence of
regulatory CD4+ T cells in adipose tissue might explain the
accumulation and/or proinflammatory signalling of ATMs
during obesity. Overall, these findings suggest a strong inter-
play between adaptive and innate immunity that together de-
termine the inflammatory characteristics of obese adipose tis-
sue. An excellent overview of the contribution of various im-
mune cells to adipose tissue biology can be found elsewhere
[24, 25]. This review will primarily focus on the function of
macrophages in adipose tissue and their contribution to the
inflammatory traits of obese adipose tissue.
Macrophages are unique in their capacity to quickly adapt
to a changing environment, causing them to embrace a variety
of phenotypes ranging from anti-inflammatory to proinflam-
matory. In virtually every tissue, macrophages are actively
involved in maintaining tissue homeostasis by clearing cellu-
lar debris, participating in tissue immune surveillance and re-
solving inflammation [26]. Although ATMs have been exten-
sively associated with the development of obesity and adipose
tissue inflammation, they are known to populate lean adipose
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tissue as well, executing numerous functions crucial for main-
taining adipose tissue homeostasis [27].
In this review, we will touch upon both well established
and recently identified functions of macrophages in lean and
obese adipose tissue. The origin of macrophages residing in
lean and obese adipose tissue will be addressed and several
triggers that may account for an increase in number and a
phenotypical switch of ATMs during the development of obe-
sity will be discussed. Finally, this knowledge is used to pin-
point relevant future research directions to establish potential
therapeutic targets for shifting macrophage phenotype and
function in order to promote adipose tissue health.
What are the functions of macrophages in adipose
tissue?
ATMs and efferocytosis In 1908, Elie Metchnikoff received
the Nobel Prize for his important discovery of the phagocytic
activity of macrophages. Nowadays phagocytosis is still con-
sidered to be the most prominent function of macrophages.
Although Metchnikoff specifically described the engulfment
of microbes, phagocytosis also encompasses the engulfment
of apoptotic endogenous cells in a process termed
‘efferocytosis’ [28]. Efficient efferocytosis licenses anti-
inflammatory removal of aged or damaged cells by macro-
phages and is crucial to maintain homeostasis in tissues where
cellular turnover occurs [28, 29]. Cellular turnover is also
active in adipose tissue, characterised by continuous removal
of adipocytes and their replacement by new adipocytes.
Depending on the study population, the adipose tissue depot
studied and the methodology used, calculations of the rate of
adipocyte turnover in adults range from 10% per year [30] to
up to 58–106% per year [31]. Since the total number of adi-
pocytes in adipose tissue is thought to be set during childhood
and thus to remain stable in adults [30, 32], probably a con-
tinuous cycle of cell death and replenishment exists in which
macrophages presumably play a key role. Indeed, studies in
which excessive adipocyte death is induced through activation
of caspase 8 [33] or ongoing stimulation of lipolysis [34] have
revealed anti-inflammatory macrophage accumulation around
dead adipocytes, pointing to the need for macrophages during
removal of dead adipocytes and the capacity of ATMs to clear
high numbers of dead adipocytes while maintaining an anti-
inflammatory state . The importance of efficient efferocytosis
becomes apparent in several chronic inflammatory diseases,
such as cystic fibrosis, chronic obstructive pulmonary disease
and asthma, where ineffective clearance of dead cells has been
identified as important source of proinflammatory signalling
[29]. In obese adipose tissue, macrophages surrounding dead
adipocytes in CLSs demonstrate proinflammatory features
[6–8]. Since efficient efferocytosis is known to be accompa-
nied by an anti-inflammatory macrophage trait, the presence
of proinflammatory ATMs surrounding dead adipocytes in the
obese state might reflect futile adipocyte clearance contribut-
ing to adipose tissue inflammation.
ATMs, adipocyte lipolysis and lipid buffering Building
upon their unique role as professional phagocytes, recent data
suggest that macrophages facilitate acute metabolic tasks ex-
ecuted by the adipose tissue. During lipolysis induced by ei-
ther fasting or pharmacologic adrenergic activation, macro-
phages rapidly infiltrate the adipose tissue and adopt an anti-
inflammatory phenotype [35]. In adipose tissue, macrophages
buffer lipolysis by taking up and storing excessive amounts of
adipocyte-released lipids, supervising gradual lipid release in-
to the bloodstream [35–37]. Recently, macrophages have also
been linked to controlling adipocyte lipolysis during cold ex-
posure. Upon exposure to cold, anti-inflammatory macro-
phages have been reported to secrete catecholamines to stim-
ulate adipocyte lipolysis in both inguinal and brown adipose
tissue [36, 38–40]. These acute challenges appear to promote
macrophage mobility and quick adaptation to a changing en-
vironment facilitating tissue flexibility.
Interestingly, 7 days of continuous infusion of a β3-
adrenergic receptor agonist to induce adipocyte lipolysis not
only results in an influx of anti-inflammatory macrophages
that adopt a lipid-laden cell appearance, it also increases the
presence of dead adipocytes and the formation of CLSs.
Within these CLSs, anti-inflammatory macrophages have
been found to recruit and stimulate platelet-derived growth
factor receptor (PDGFR)α+ adipocyte progenitors to differen-
tiate [34]. Intriguingly, these adipogenic clusters near CLSs
point to a direct link between efferocytosis, lipid buffering and
adipose tissue remodelling by macrophages in lean adipose
tissue.
In obese adipose tissue, macrophages surrounding dead
adipocytes in CLSs also formmultiple intracellular lipid drop-
lets and activate transcriptional programs involved in lyso-
somal lipolysis [41]. The presence of lipid-filled macrophages
in CLSs of obese adipose tissue in both humans [42] and mice
[8] is indicative of macrophages attempting to buffer and pro-
cess excessive amounts of lipids originating from adipocytes
in a similar fashion to that observed in lean adipose tissue.
However, increased spilling of NEFAs during obesity is sug-
gestive of unsuccessful lipid buffering by ATMs. Thus, al-
though engulfment and storage of lipids by ATMs seems to
hold functional relevance in both lean and obese adipose tis-
sue, in obesity the lipid buffering capacity of ATMs appears to
be insufficient.
ATMs and adipogenesis The close correlation between adi-
pocyte death and new cell formation through adipogenesis
that has been observed in lean adipose tissue may not hold
true during obesity. While macrophages in obese adipose tis-
sue have been found to populate adipogenic clusters and
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facilitate angiogenesis and adipogenesis, adipogenic clusters
are formed at sites away from CLSs [34, 43, 44]. This might
relate to the proinflammatory state of macrophages in CLSs in
obese adipose tissue. Although it has been proposed that pro-
inflammatory signalling is needed for efficient adipogenesis to
occur [45], multiple cell culture experiments have demonstrat-
ed that proinflammatory macrophages inhibit both prolifera-
tion and differentiation of adipogenitor cells [46–49]. The
proinflammatory phenotype of macrophages in CLSs of obese
adipose tissue may suppress adipogenesis and thus explain the
appearance of adipogenic clusters away from inflammatory
CLSs [34].
In contrast to studies postulating a role for macrophages in
adipogenesis, other studies have argued that ATMs inhibit
adipogenesis in obese adipose tissue [49, 50]. For example,
it was found that exposure of adipocyte progenitors to condi-
tioned medium of CD14+ cells from obese adipose tissue
blocks adipogenesis [49]. A prominent factor involved in sup-
pressing adipogenesis is Wnt-5a, which is abundantly
expressed in ATMs and circulating monocytes from individ-
uals with obesity and type 2 diabetes compared with lean
individuals [50]. Overall, the effect of macrophages on adipo-
genesis in obese adipose tissue is still being debated. One
might hypothesise that the role of macrophages shifts during
the progression of obesity from a predominant role in stimu-
lating adipogenesis at the start of adipose tissue expansion to
inhibiting adipogenesis once obesity progresses. The observa-
tion that adipogenic clusters containing macrophages appear
at an early stage of adipose tissue expansion during obesity,
yet decline in number upon the progression of obesity, sup-
ports this hypothesis [43]. Reduced adipogenesis at later
stages of obesity would promote hypertrophy of adipocytes
to allow for storage of the excess amounts of lipids entering
the adipose tissue, which is in turn linked to metabolic dys-
function such as adipocyte insulin resistance [51, 52]. Indeed,
increased adipocyte size has been found to correlate with mac-
rophage presence in obese adipose tissue [53, 54]. However,
future in vivo studies will be needed to further unravel the role
of ATMs in adipogenesis and adipocyte hypertrophy in both
lean and obese adipose tissue. In conclusion, multiple func-
tions of macrophages in lean adipose tissue, including the
prevention of lipid spillover into the circulation and li-
censing adipose tissue remodelling, appear to be im-
paired in obese adipose tissue. It is likely that impair-
ment of these functions executed by ATMs contributes
to loss of adipose tissue homeostasis in obese individ-
uals. Differential metabolic and inflammatory traits of
ATMs residing in either lean or obese adipose tissue
may underlie shifts in its functional output and thus
total adipose tissue functioning. Hence, careful identifi-
cation of ATM phenotypes in lean and obese individuals
might provide evidence for functional rewiring of ATMs
upon the development of obesity.
What are the effects of the adipose tissue
environment on macrophage phenotype?
Macrophage phenotype in lean vs obese adipose tissue
Besides increasing in number, ATMs are known to dramatically
change their phenotype during obesity. It has been suggested
that the majority of the macrophage population in adipose tis-
sue of obese mice consists of F4/80+CD11c+ or ‘classically
activated’M1macrophages, characterised by increased expres-
sion levels of TNFα and inducible nitric oxide synthase (iNOS)
[8]. By contrast, most of the macrophages in lean adipose tissue
can be identified as F4/80+CD206+CD301+CD11c− macro-
phages, resembling an alternatively activated M2 phenotype
that is characterised by the expression of genes encoding anti-
inflammatory proteins including Ym1, arginase 1 and IL-10 [8,
27]. A balanced ‘M0’ F4/80+CD206−CD11c− phenotype has
also been reported [55], supporting an even greater diversity of
inflammatory macrophage subtypes in the adipose tissue.
However, in light of the metabolic functions performed by
ATMs, a classification based on their inflammatory properties
may not suffice. In line with this hypothesis, both M1 and M2
markers have been identified on a phenotypical heterogeneous
population of macrophages in obese adipose tissue [56].
Interestingly, a metabolic classification has recently been put
forward, characterised by increased lysosomal biogenesis and
subsequent lipid catabolism as a hallmark of ATMs in obese
adipose tissue [41]. Rather than cytokine-driven proinflamma-
tory activation of ATMs, fatty acids (FAs) are the main trigger
for metabolic activation of ATMs in obese adipose tissue.
Importantly, metabolic changes in lipid metabolism may pre-
dominantly underlie inflammatory activation of macrophages
in adipose tissue, promoting an inflammatory phenotype of
ATMs that may not fit into any of the classically defined in-
flammatory macrophage subtypes [57].
Macrophages in human vs mouse adipose tissue In parallel
with an increase in ATMs during obesity in mice, macrophage
numbers have also been found to increase in human obese
adipose tissue [5, 7]. In contrast to the proinflammatory phe-
notype of macrophages found in many animal studies, an
‘M2-type’ macrophage with remodelling capacity, yet still
capable of secreting substantial quantities of proinflammatory
cytokines, has been identified in adipose tissue of obese indi-
viduals [58]. The mixed inflammatory phenotype of ATMs in
obese individuals is further illustrated by the presence of both
CD206 and CD11c on the ATMmembrane, markers generally
used to distinguish between M2- and M1-type macrophages
[59]. Despite their anti-inflammatory characteristics, this pop-
ulation of CD11c+CD206+ macrophages has been associated
with insulin resistance [60]. Interestingly, the M2 macrophage
marker CD163 has even been proposed to be the single mac-
rophage marker that significantly correlates with HOMA-IR
[61]. As mentioned before, less pronounced correlations
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between ATM numbers and insulin resistance have been
found in humans, compared with mice [62–64]. It is likely
that inter-individual differences in the development of adipose
tissue inflammation during obesity exist and contribute to the
inconsistency in reported correlations betweenATMs, adipose
tissue inflammation and the development of insulin resistance
in humans.
Location: visceral vs subcutaneous adipose tissue Adipose
tissue is stored at various locations throughout the body,
characterised by specific metabolic and inflammatory proper-
ties. Both subcutaneous (scAT) and visceral (vAT) storage
depots exist, which are identified based on their anatomical
location and differentially contribute to the development of
metabolic abnormalities [65]. Epidemiological evidence dem-
onstrates that vAT mass is a dominant risk factor for the de-
velopment of metabolic abnormalities including insulin resis-
tance [65]. Ex vivo experiments have shown that the inflam-
matory status, determined by the release of cytokines, is ele-
vated in vATcompared with scAT [66]. This would imply that
the number and/or phenotype of macrophages differ between
the two adipose tissue depots. Indeed, various studies have
shown an enhanced number of macrophages in vAT vs scAT
[62, 67]. However, others have failed to report any differences
in macrophage cell numbers [66]. In animal studies, bigger
adipocytes were found in scAT compared with vAT, which
negatively correlated with the number of CLSs in the adipose
tissue depots [10]. Moreover, distinct rates of adipocyte turn-
over, adipocyte lipolysis and blood flow, with consequences
for oxygen and nutrient availability, have been detected in
scAT vs vAT [68, 69]. Although controversy about the differ-
ent characteristics exists, distinct microenvironments in the
adipose tissue depots might importantly affect macrophage
phenotypes. Phenotypical differences in macrophages that
populate either vATor scATmay be exemplified by the higher
expression of proinflammatory cytokines by ATMs in vAT
[67, 70, 71].
In general, most studies are mainly focused on determining
the inflammatory phenotypes of ATMs. However, in line with
the metabolic functions executed by ATMs, inflammatory
markers may not suffice to distinguish functional from dys-
functional ATMs. It would be interesting to unravel whether
macrophages within human adipose tissue display a metabol-
ically activated phenotype, as has been identified recently in
mice [57]. Moreover, deciphering what type of metabolic and
inflammatory changes in ATMs finally result in functional
differences in obese vs lean adipose tissue might improve
our understanding of obesity-induced adipose tissue inflam-
mation. Multiple triggers may underlie the macrophage phe-
notype, explaining the distinct responses of ATMs to several
challenges in obese and lean adipose tissue. In order to shed
light on such triggers, one should consider how and where the
phenotype of the ATMs is being affected.
From where do ATMs originate?
Contrasting with the prevalent idea that all tissuemacrophages
are derived from circulating monocytes, novel techniques that
allow fate mapping have revealed that not all tissue-resident
macrophages originate from monocyte precursors [72]. Many
resident tissue macrophages are established during early em-
bryonic development and are maintained during adulthood
independently of an influx of blood monocytes [73].
However, inflammation has been shown to drive the recruit-
ment of blood monocyte-derived macrophages that replace
embryonically established resident macrophage populations
in the myocardium and other tissues [74]. Surprisingly little
is known about the origin of adipose tissue-resident macro-
phages and the maintenance of this population.
Monocyte recruitment It is well established that adipocytes
are able to produce specific adipokines that function as
chemoattractants for circulating monocytes. Monocyte
chemoattractant protein-1 (MCP-1) is one such chemokine
that is known to be produced in large amounts by adipocytes
and is robustly increased in obesity [75]. Indeed, overexpres-
sion of MCP-1 in adipose tissue promotes macrophage accu-
mulation [76]. Interestingly, the presence of the C–C chemo-
kine receptor (CCR) type 2, which allows monocytes to re-
spond to MCP-1, is a typical characteristic of newly recruited
macrophages that is used to distinguish them from resident
macrophages in a variety of tissues [74] including fat [7].
These observations imply that monocyte recruitment through
MCP-1 is important in populating adipose tissue with macro-
phages, and that this pathway is enhanced in the presence of
obesity.
In addition to increased secretion of MCP-1 by adipose
tissue, obesity is characterised by a significantly increased
number of CCR2 molecules on circulating monocytes [77].
Moreover, monocytes from obese individuals demonstrate a
higher chemotactic activity, which is associated with both in-
sulin resistance and CCR2 expression [77]. Interestingly, the
migratory behaviour itself might be an important influence on
macrophage phenotype. This is illustrated by the finding that
the inflammatory state is linked to the migratory capacity of
macrophages into adipose tissue [6, 8, 78]. In addition to a
higher degree of chemotaxis, CCR2+ tissue macrophages may
have an increased inflammatory phenotype compared with
CCR2− tissue macrophages, which is illustrated by an induc-
tion of genes involved in the regulating of the NLRP3
inflammasome, at least in the myocardium [74]. The NLRP3
inflammasome allows processing and release of active IL-1β.
IL-1β controls inflammatory responses and is involved in the
development of insulin resistance [79, 80]. Similar differences
appear to exist in ATMs isolated from obese animals shown
by enhanced expression of CCR2 and inflammatory cytokines
compared with the ATMs of lean animals [7]. However,
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monocyte recruitment to adipose tissue may not solely depend
on MCP-1-controlled pathways, as the absence of MCP-1
does not completely curtail monocyte influx into adipose tis-
sue [81]. Indeed, other chemokine receptor/ligand complexes
have been shown to play a role in these processes, including
CCR5 [82].
Bone marrow myelopoiesis Recent evidence has shed light
on mechanisms and signals that have a vital role in controlling
the recruitment of monocytes during obesity and go beyond
MCP-1 and other chemokine-signalling modules. Indeed, the
bone marrow has been identified as an important contributor
to the ATM pool [5, 83]. The development of obesity has been
found to stimulate bone marrow myelopoiesis, which licenses
the ongoing infiltration of monocytes into adipose tissue [84,
85]. Interestingly, it appears that signals from obese adipose
tissue actively enhance bone marrow myelopoiesis partly via
local activation of the alarmin S100A8/A9, which drives pro-
duction of IL-1β [84]. Other adipokines have also been shown
to govern myelopoiesis, including leptin [85], further corrob-
orating the observation that adipose tissue appears to deter-
mine bone marrow function via remote control. It is worth
noting that fat residing within the bone marrow is known to
express various cytokines and adipokines that change during
the development of obesity and type 2 diabetes and might also
be involved in the remodelling and activation of bone marrow
cell populations [86]. Even though these observations shed
some light on the mechanism of action involved, many issues
concerning recruitment remain unresolved. In addition to ad-
ipose tissue-derived IL-1β, are haematopoietic factors in-
volved in the control of myelopoiesis during obesity as well?
Are signals from the adipose tissue also responsible for con-
trolling bone marrow myelopoiesis in lean conditions? And
are monocytes phenotypically different when originating from
bone marrow during lean vs obese conditions? One line of
evidence suggests that monocytes originating from bone mar-
row of lean or obese animals have a similar migration capac-
ity. Using PKH26 staining to track monocytes, ATM accumu-
lation was found to be enhanced in obese recipient mice com-
pared with lean mice, independently of the origin of donor
monocytes from either obese or lean animals [87]. These re-
sults imply that adipose tissue-derived signals determine local
macrophage numbers. Nonetheless, it has been demonstrated
that bone-derived macrophages from HFD-fed mice display
an enhanced inflammatory phenotype compared with macro-
phages derived from bone marrow of lean animals [88].
Moreover, haematopoietic stem cells from obese mice harbour
an enhanced capacity to develop into inflammatory CD11c+
ATMs after bone marrow transplantation [89]. Together these
data suggest that adipose tissue-derived factors determine both
the infiltration and differentiation of monocytes and that obe-
sity affects the characteristics of the bone marrow cell
population, ultimately translating into phenotypically different
monocytes infiltrating lean and obese adipose tissue.
Local regulation of ATM numbers In addition to recruit-
ment during obesity, multiple lines of evidence suggest that
adipose tissue is equipped with tools allowing for local regu-
lation and proliferation of ATM pools independently of the
influx of blood precursors. vAT that is part of human omen-
tum displays enhanced myelopoiesis during acute inflamma-
tory conditions, which is suggestive for in situ production of
cell populations in the abdomen [90, 91]. In line with these
results, the presence of haematopoietic stem/progenitor cell
populations in mouse white adipose tissue has been reported.
The capacity of these cells to differentiate into myeloid and
lymphoid lineages was similar to that of bone marrow-derived
haematopoietic cells [92], yet no evidence currently exists
supporting a fundamental role for local myelopoiesis in deter-
mining ATM numbers in obese adipose tissue. Another path-
way contributing to influx-independent pathways that nourish
ATM numbers concerns the involvement of pre-adipocytes
that have been assigned with characteristics that closely
resemble macrophages. 3T3-L1 pre-adipocytes, a frequently
used model to study adipogenesis in vitro, display
macrophage-like functions that are lost upon differentiation
towards adipocytes [93]. Moreover, pre-adipocytes isolated
from adipose tissue carry out manymacrophage-like functions
including phagocytosis and express macrophage-specific an-
tigens including F4/80, macrophage 1 antigen (Mac-1) and
CD45 [94]. Overall, these results imply closely resembling
phenotypes of pre-adipocytes and macrophages.When receiv-
ing the appropriate signals, pre-adipocytes may efficiently and
rapidly adapt and execute ATM functions.
Besides the contribution of local precursors, local prolifer-
ation has been held responsible for increasing ATM numbers
during obesity [95]. Moreover, ATMs in obese adipose tissue
have been postulated to have reduced migration capacity
through increased netrin-1 expression that traps them in adi-
pose tissue [96]. Finally, reduced apoptosis of resident ATMs
has been suggested to account for enhanced ATM numbers
during obesity, independently of monocyte influx [97].
To summarise, the origin of ATMs in lean and obese adi-
pose tissue is still a matter of debate. The presence of specific
cell surface markers on ATMs might help us learn more about
their origin. Moreover, lineage tracing of ATMs using time-
lapse microscopy, cell labelling and/or genetic markers will
help us understand the origin of ATMs. On the basis of the
currently available data, ATMs appear to be mainly derived
from bone marrow-controlled pathways involving adipose-
derived signals. Other lines of evidence suggest that local
mechanisms may determine macrophage numbers in adipose
tissue, including prolonged survival or increased retention of
ATMs. Probably, various pathways at multiple levels are at
work to set ATM numbers in adipose tissue. Whether the
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number of ATMs is primarily regulated at the level of the bone
marrow or is determined by local factors in the adipose tissue
will need further study.
Drivers of the adipose tissue macrophage phenotype
Both during myelopoiesis and in the circulation, monocytes
can be primed by different factors that will eventually contrib-
ute to their migration and inflammatory fate after infiltration
into the adipose tissue. It is likely that adipose tissue-derived
factors will further determine the final ATM phenotype, which
may differ between lean and obese adipose tissue. Some im-
portant triggers that shape the metabolic, inflammatory and
functional traits of ATMs will be discussed below.
As explained earlier, other immune cells residing in the
adipose tissue probably shape ATM phenotype as well, but
these will not be discussed in this review. The same also ap-
plies to various adipokines that are known to be differentially
secreted by lean rather than obese adipose tissue. Their role in
affecting the phenotype of macrophages has been reviewed
elsewhere [98, 99].
Hypoxia Both in humans and mice, rapid adipose tissue mass
expansion during the development of obesity occurs without a
concurrent increase in blood flow towards the tissue [100].
Indeed, animal studies have demonstrated that obese adipose
tissue is characterised by hypoxic areas and an increased ex-
pression of hypoxia-related genes including HIF1α [19,
101–103]. In humans, oxygen levels in the adipose tissue
are much harder to measure, and this technical challenge like-
ly contributes to the contradictory results that have been re-
ported so far, ranging from decreased oxygen tension [104,
105], unaltered oxygen tension, and even to increased oxygen
tension [106] in obese adipose tissue.
As a result of their profound increase in size upon the
development of obesity, adipocytes are generally thought to
suffer from hypoxia in obese adipose tissue. Hypoxic condi-
tions in adipocytes promote angiogenesis and fibrotic remod-
elling and have often been associated with the development of
adipose tissue insulin resistance [102, 103, 107].
Only recently has attention been directed to the effects of
hypoxic conditions on macrophages in the adipose tissue. In
line with adipocytes, ATMs from obese adipose tissue have
increased expression levels of hypoxia-related genes [101,
108]. It is not unthinkable that prolonged hypoxia is one of
the driving forces behind the proinflammatory phenotype of
macrophages in obese adipose tissue.When CD14+ cells from
human obese vAT are exposed to hypoxic conditions, the se-
cretion of proinflammatory cytokines is enhanced in compar-
ison with culturing under normoxic conditions [70].
Moreover, human macrophages derived from circulating
monocytes held under hypoxic conditions show an increased
inflammatory response when exposed to the saturated fatty
acid (SFA) palmitate [109]. Interestingly, in vivo, M1-like
macrophages accumulate more pimonidazole, a hypoxia
probe, than do anti-inflammatory macrophages in the adipose
tissue of obese mice, and display higher expression levels of
hypoxia-related genes including Hif1α [101]. Together these
data underline a direct link between the hypoxic state of ATMs
and their inflammatory phenotype in obese adipose tissue.
Importantly, the response ofmacrophages to hypoxia might
depend on their initial inflammatory state. Indeed, it has been
proposed that stimulation of bone marrow-derived macro-
phages with IL-4 prior to hypoxia exposure decreases the
expression of proinflammatory genes, while leaving
hypoxia-related gene expression unaltered [101].
Alternatively, differential responses of macrophages to hyp-
oxia could also relate to the presence of two different isoforms
of hypoxia-inducible factor (HIF). HIF1α is the most well-
known isoform and mediates a shift towards glycolysis,
known as the Warburg effect [110]. Inflammatory stimuli are
prominent stimulants of HIF1α activity, inducing rapid ATP
production independent of oxygen [110, 111]. During hypoxic
conditions HIF1α activity is also considered to be crucial to
maintain energy levels [100], although other transcription fac-
tors probably play an additional role [109]. In addition to
fuelling a metabolic switch, HIF1α enhances proinflammato-
ry signalling via IL-1β transcription [110]. The control of IL-
1β expression might provide a direct link between HIF1α
activity in obese ATMs, either activated via hypoxia or inflam-
matory signalling, and the presence of insulin resistance.
The isoform HIF2α is also upregulated under low oxygen
levels. While HIF1α increases the glycolytic flux and proin-
flammatory signalling, HIF2α is associated with a more anti-
inflammatory macrophage phenotype [112, 113].
Interestingly, in obese adipose tissue HIF2α is predominantly
upregulated in M2-like macrophages [108] and peritoneal
macrophages overexpressing HIF2α show a blunted increase
in TNFα expression on co-culturing with obese adipose tissue
[108]. Adipocyte-specific deletion ofHif2α has been linked to
adipose tissue inflammation, glucose intolerance and insulin
resistance [114] but so far no studies specifically targeting
HIF2α in macrophages have been conducted.
Overall, the inflammatory state of macrophages might be
linked to the relative presence of HIF isoforms that may influ-
ence the metabolic and inflammatory response of ATMs under
hypoxic conditions. Importantly, in addition to hypoxia, one
should not ignore the fact that HIF-dependent gene expression
can also be regulated independently of oxygen availability,
through the involvement of inflammatory-related signals. In ad-
dition to direct effects of hypoxia on macrophages, signals orig-
inating from hypoxic adipocytes may also shape the phenotype
of ATMs in obese adipose tissue. Indeed, in vitro experiments
have revealed that adipocytes exposed to hypoxic conditions
release potential stressors that affect macrophage function.
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Examples include the proinflammatory adipokines IL-6,
visfatin, leptin and macrophage migration inhibitory factor
(MIF) [100]. Importantly, prolonged exposure to hypoxia might
also lead to adipocyte cell death and release of intracellular
content which subsequently affects the phenotype of ATMs.
Adipocyte cell death In animal studies, cell death in obese
adipose tissue has been well established. Dead adipocytes that
have lost membrane integrity are surrounded by macrophages
that cluster in CLSs and together form proinflammatory, fi-
brotic lesions [115]. Signals released from dying cells are
known to act as strong chemoattractants and affect immune
responses [116, 117]. One example is the nuclear protein high-
mobility group box 1 (HMGB1), which acts as a danger signal
that attracts and activates immune cells [118]. Interestingly,
HMGB1 levels are increased in obese adipose tissue and are
associated with inflammation [119, 120]. In addition to
HMGB1, other cellular proteins with intrinsic inflammatory
features are released upon cell death and may skew ATM
phenotypes in obese adipose tissue. Uric acid, adenosine,
ATP and galectins are among some of these so-called ‘danger
signals’ that affect inflammatory macrophage responses [116,
117, 121].
The type of adipocyte cell death occurring in adipose tissue
may determine the inflammatory phenotype of macrophages
as well. Apoptotic cells induce a predominant anti-
inflammatory response, whereas necrotic cells stimulate pro-
inflammatory cytokine secretion [117]. Dead cells that are not
effectively cleared are known to turn into secondary necrotic
cells releasing their noxious content to induce proinflamma-
tory signalling, autoimmunity and tissue damage [122–125].
Although impaired clearance of dead cells has been causally
linked to various chronic inflammatory diseases [29], to date
there have been no extensive studies on the contribution of
adipocyte death to inflammation during obesity. Some studies
have reported necrotic adipocyte cell death in obese adipose
tissue, with membrane rupture and release of cell content [9].
However, others postulate programmed necrotic cell death
[126], programmed pyroptosis [127] or even apoptosis [128]
of adipocytes in obese adipose tissue, making it difficult to
draw conclusions on the effect of adipocyte cell death onATM
phenotype. Considering the profound consequence for mac-
rophage phenotype found in other organs, examination of the
type of adipocyte cell death occurring in obese adipose tissue,
but also during regular cell turnover in lean adipose tissue, is
of relevance.
Importantly, adipocyte cell death is unique in the fact that it
leads to the release of substantial amounts of lipids and one
might hypothesise that prolonged exposure to excess lipids
affects ATM phenotype.
Lipotoxicity A lipid-rich environment during the develop-
ment of obesity may represent an important metabolic stressor
for ATMs. In general, there are three ways through which
ATMs are exposed to lipids; via chylomicrons or VLDLs, by
adipocyte lipolysis, or after adipocyte cell death.
Hyperlipidaemia seems not to lead to macrophage accumula-
tion in obese adipose tissue [129], indicating that lipids
resulting from adipocyte lipolysis and adipocyte cell death
represent the main causes of excessive lipid accumulation in
ATMs during obesity. However, the exact contribution of ad-
ipocyte lipolysis is also somewhat controversial. On the one
hand higher basal rates of lipolysis have been observed in
adipocytes of obese individuals [130]. In line with this, adipo-
cyte hypertrophy and TNFα exposure, which are both elevat-
ed in obese adipose tissue, have been linked to increased ad-
ipocyte lipolysis [131–133]. On the other hand, decreased
basal lipolytic rates [134] and reduced catecholamine-
induced lipolysis by insulin resistant adipocytes in obese ad-
ipose tissue [135, 136] have been reported as well, and are
indicative of lower lipolysis rates in obese adipose tissue.
Nonetheless, although the exact source is still a matter of
debate, macrophages in obese adipose tissue are exposed to
excess lipids as illustrated by their lipid-laden appearance.
Exposure to FAs is known to influence macrophage pheno-
type profoundly. Importantly, SFAs induce a proinflammatory
macrophage phenotype via Toll-like receptor (TLR)-induced
NF-kB activation [137]. The TLR-family member 4 (TLR4)
translates most of the proinflammatory effects of SFAs that
trigger TLR4 activation via binding to its adaptor molecule
fetuin-A [138, 139], although some argue that the effects of
SFAs are partly TLR-independent [57, 140]. Another source
of proinflammatory signalling finds it origin intracellularly, as
an increase in intracellular FAs is associated with endoplasmic
reticulum (ER) stress and oxidative stress, enhancing proin-
flammatory signalling and inducing insulin resistance in vivo
[141]. Moreover, SFAs and their derivatives, including
ceramides, are classified as danger-associated molecular pat-
terns (DAMPs) that are recognised by the NLRP3
inflammasome and lead to IL-1β secretion via caspase 1 ac-
tivation [142]. However, the response of macrophages upon
lipid uptake does not necessarily have to be proinflammatory
in nature [143]. Although it has been suggested that
internalised palmitate, a very well-known SFA, promotes lipid
metabolism and limits inflammation [57], in general only un-
saturated FAs, particularly n-3 FAs, are recognised for their
anti-inflammatory properties [139, 144]. Hence, FA species
present in adipocytes may for a large part determine the degree
of lipid toxicity in macrophages. Alternatively, one might
speculate that the metabolic and inflammatory state of macro-
phages could also be involved in determining its response to
different FAs. Overall, mechanisms by which intracellular
FAs determine the inflammatory traits of macrophages are
relatively unclear. Importantly, lipid-overloaded macrophages
in obese adipose tissue [42] may trigger the production of
proinflammatory cytokines such as TNFα and IL-1β, as has
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been observed in macrophages exposed to FAs in vitro [138,
145–147], and thus contributing to the development of insulin
resistance. The type of FAs stored in the adipocyte, the
timespan of lipid exposure, the inflammatory phenotype of
the macrophage and the presence of various other inflamma-
tory signalling molecules might explain the predominant anti-
inflammatory response of ATMs in lean adipose tissue vs the
proinflammatory response in obese adipose tissue following
lipid exposure.
Hyperinsulinaemia Obesity-induced adipose tissue inflam-
mation is associated with systemic insulin resistance and
hyperinsulinaemia in obese rodents and humans. Multiple
lines of evidence suggest that insulin itself directly affects
inflammatory processes. In fact, insulin has been assigned
with both anti- and proinflammatory properties. In circulating
mononuclear cells of obese individuals, insulin inhibits NF-
kB activity, suggesting an anti-inflammatory effect [148]. By
contrast, other studies have shown that hyperinsulinaemia pro-
motes proinflammatory responses by affecting T cell regula-
tory function [149].
It is difficult to pinpoint the sole effects of insulin in vivo
during the development of obesity, as changes in many other
circulating factors accompany hyperinsulinaemia. However,
several lines of evidence suggest that insulin directly contrib-
utes to ATM homing. The start of insulin therapy in patients
diagnosed with type 2 diabetes has been shown to promote the
appearance of macrophages in scAT [150]. Intriguingly, in
both humans and mice, circulating insulin positively corre-
lates with inflammatory cytokine expression in the adipose
tissue, independently of body weight differences [151].
Recently, a mechanism of action whereby insulin may control
propagation of adipose tissue inflammation was uncovered.
Even though adipocytes become insensitive to insulin-
dependent glucose uptake during obesity, insulin is able to
enhance adipocyteMCP-1 gene expression levels aggravating
the influx of monocytes [151].
Insulin resistance has also been shown to negatively affect
macrophage function itself, especially in the context of ath-
erosclerotic disease. Although glucose uptake primarily takes
place via insulin-independent pathways involving GLUT1,
circulating monocytes express the insulin receptor machinery
and develop resistance to the effects of insulin. Interestingly,
insulin receptor deficiency on macrophages reduces their in-
flux into the adipose tissue and alleviates the development of
low-grade inflammation and systemic insulin resistance in
mice on an HFD [152]. Functional consequences of insulin
resistance include a failure to deal with ER stress, which en-
hances the risk of macrophage apoptosis and subsequent loss
of function [153]. In addition to apoptosis, primary macro-
phages isolated from ob/obmice have a defect in efferocytosis
that was associated with defective phosphoinositide (PI)3
kinase activity, whereas cells lacking the insulin receptor were
protected [154].
It remains to be determined whether insulin resistance de-
velops in ATMs in obese adipose tissue. Moreover, the func-
tional consequences and possible contributions to adipose tis-
sue inflammation are currently unknown. Another interesting
aspect involves the development of insulin resistance in cir-
culating monocytes [155]. It is not unthinkable that insulin
resistance in circulating monocytes may promote functional
changes leading to altered migration and inflammatory prop-
erties. Studies involving monocytes lacking specific parts of
the insulin signalling machinery would shed light on the role
of this pathway in shaping ATM phenotypes both during lean
and obese conditions.
Hyperglycaemia Chronic hyperglycaemia is known to induce
insulin resistance by mechanisms that may partly be conveyed
by an enhanced inflammatory state. Indeed, there is a substan-
tial amount of evidence demonstrating proinflammatory effects
of prolonged periods of hyperglycaemia. In humans,
hyperglycaemia is associated with inflammation in individuals
with diabetes [156]. Similar data has been generated using var-
ious animal models where the induction of hyperglycaemia
using streptozotocin (STZ)-mediated disruption of pancreatic
beta cells drives monocyte recruitment to tissues and promotes
inflammation [157]. Other approaches to induce short-term pe-
riods of hyperglycaemia, including clamping, trigger proin-
flammatory responses in adipose tissue of rats as well [158].
In both adipocytes and macrophages, harmful effects of
prolonged exposure to high levels of glucose have been re-
ported. In vitro approaches in which adipocytes are cultured in
mediumwith 25mmol/l glucose for prolonged periods of time
revealed increased production of various proinflammatory cy-
tokines including IL-6 [158], and similar observations have
been made in immune cells [159]. Moreover, hyperglycaemia
has been shown to interfere with IL-4 action to polarise mac-
rophages towards an alternatively activated state illustrated by
decreased expression of M2 markers and a reduction in argi-
nase functional activity, compared with cells treated under
normoglycaemic conditions [160]. It has been postulated that
the induction of reactive oxygen species (ROS) as a conse-
quence of hyperglycaemia evokes inflammatory responses.
An important molecular switch that translates the presence
of hyperglycaemia into proinflammatory conditions is the
thioredoxin-interacting protein (TXNIP). TXNIP expression
is enhanced by high levels of glucose and in the presence of
diabetes via the transcription factor carbohydrate response
element-binding protein (ChREBP) and regulates a variety
of processes including redox state and inflammation [161].
Deletion of Txnip using small interfering (si)RNA approaches
prevents hyperglycaemia-induced ROS generation and the in-
duction of inflammation [162]. Moreover, TXNIP has been
linked to inflammasome activation in macrophages [163], a
Diabetologia (2016) 59:879–894 887
pathway known to contribute to adipose tissue inflammation
and insulin resistance [79, 164]. In adipose tissue, glucose-
induced activation of TXNIP mediates IL-1β mRNA expres-
sion levels and intracellular pro-IL-1β accumulation [66].
The consequences of hyperglycaemia may also be
conveyed via changes in cellular metabolism leading to
alterations in intermediate metabolites. It has been doc-
umented that cultured adipocytes exposed to high levels
of glucose produce and secrete enhanced quantities of
lactate [165]. Interestingly, diabetes is associated with
markedly increased lactate production in adipocytes de-
rived from obese adipose tissue [166]. Lactic acid, se-
creted from tumour cells as a by-product of aerobic or
anaerobic glycolysis, has been shown to drive an M2-
like polarisation of tumour-associated macrophages
[167]. Whether lactic acid secreted by adipocytes may
alter ATM phenotype is currently unknown.
High levels of glucose may thus represent an important
trigger that activates proinflammatory changes in macro-
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periods of hyperglycaemia, either during a clamp procedure or
postprandially, and chronic periods in the presence of obesity
and insulin resistance, appear to induce proinflammatory mac-
rophage characteristics.
A future challenge: identification of key regulators
of macrophage phenotype
Macrophages can be identified via specific transcription factors
that control tissue-tailored transcriptional programs and allow
the cells to adopt extremely tissue-specific functions. An ele-
gant example is the identification of GATA-6 as master regula-
tor of the peritoneal-specific gene transcriptional program. By
comparing the transcriptome of various tissue macrophages
including those from lung, liver, adipose tissue and peritoneum
[90], the authors identified a set of genes controlled by GATA-6
specifically expressed in peritoneal macrophages. Using a sim-
ilar approach, we have re-analysed their dataset to pinpoint
ATM-specific genes leading to the identification of
transforming growth factor (TGF)β and IL-4 as impor-
tant upstream regulators. The identification of anti-
inflammatory upstream regulators in ATMs isolated
from lean animals is not surprising, yet it does demon-
strate the usefulness of this approach. Comparing tran-
scriptional regulators of ATMs during various conditions
may bypass the rather complex quest for responsible
triggers, and may help to unravel important pathways
and molecules that underlie the distinct metabolic, in-
flammatory and functional traits of ATMs as a conse-
quence of multiple triggers present in lean vs obese
adipose tissue.
Because of the high versatility of macrophages, which have
a phenotype largely dependent on their environment, conclu-
sions solely based on in vitro studies should be taken with
caution. Rather, in vivo profiling of macrophage phenotype
via several techniques, including metabolomics and tran-
scriptomics, and identification of key regulators of distinct
macrophage phenotypes, residing in different adipose tissue
depots and/or during the development of obesity and insulin
resistance in both humans and mice, will advance our knowl-
edge on adipose tissue biology. Determining a causal relation-
ship between triggers, a switch in the metabolic and inflam-
matory status of ATMs and ATM function will be an impor-
tant challenge. This information will be crucial for our under-
standing of initial triggers that ultimately link obesity to
adipose tissue inflammation and the development of in-
sulin resistance, and might provide us with future ther-
apeutic targets. An overview of stressors that may de-
termine the phenotype of ATMs in lean vs obese con-
ditions and the subsequent consequences for adipose
tissue function are shown in Fig. 1.
Limiting adipose tissue inflammation by targeting
macrophage metabolism
The presence of adipose tissue inflammation translates the
development of obesity into insulin resistance and type 2 dia-
betes. Macrophages play a key role in maintaining adipose
tissue homeostasis, yet fuel adipose tissue inflammation upon
the development of obesity.
Current efforts to unravel adipose tissue-specific functions
of macrophages have revealed an essential role in lipid buff-
ering for ATMs, alongside their more conventional functions
such as clearing cellular debris and participating in tissue im-
mune surveillance to maintain homeostasis. Importantly, both
in lean and obese adipose tissue, lipid storage by macrophages
prevents spillover into the circulation. However, the metabol-
ically activated macrophage that resides in obese adipose tis-
sue appears to be continuously exposed to an overabundance
of lipids. Chronic lipid overloading of ATMs translates into a
proinflammatory phenotype and may drive dysfunction of
ATMs, ultimately fuelling the inflammatory traits of obese
adipose tissue.
This new knowledge might shift intervention approaches
away from targeting the inflammatory traits of ATMs, towards
targeting their metabolic programming. Interventions aimed at
increasing metabolic capacity might be used to reprogram
macrophage metabolism, allowing macrophages to cope with
metabolic challenges during obesity, in order to maintain ad-
ipose tissue homeostasis.
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